AAAAAA

   
Results: 1-25 |
Results: 25
EFFECTS OF INTERLEUKIN-12 ON THE INDUCTION OF CYTOTOXIC T-LYMPHOCYTESFROM THE REGIONAL LYMPH-NODE LYMPHOCYTES OF PATIENTS WITH LUNG ADENOCARCINOMA
Authors: HANAGIRI T YOSHINO I TAKENOYAMA M SO T FUJIE H IMABAYASHI S EIFUKU R YOSHIMATSU T OSAKI T NAKANISHI R ICHIYOSHI Y NAGASHIMA A NOMOTO K YASUMOTO K
Citation: T. Hanagiri et al., EFFECTS OF INTERLEUKIN-12 ON THE INDUCTION OF CYTOTOXIC T-LYMPHOCYTESFROM THE REGIONAL LYMPH-NODE LYMPHOCYTES OF PATIENTS WITH LUNG ADENOCARCINOMA, Japanese journal of cancer research, 89(2), 1998, pp. 192-198
AUTOLOGOUS TUMOR-SPECIFIC CYTOTOXIC T-LYMPHOCYTES IN A PATIENT WITH LUNG ADENOCARCINOMA - IMPLICATIONS OF THE SHARED ANTIGENS EXPRESSED IN HLA-A24 LUNG-CANCER CELLS
Authors: TAKENOYAMA M YOSHINO I FUJIE H HANAGIRI T YOSHIMATSU T IMABAYASHI S EIFUKU R NOMOTO K YASUMOTO K
Citation: M. Takenoyama et al., AUTOLOGOUS TUMOR-SPECIFIC CYTOTOXIC T-LYMPHOCYTES IN A PATIENT WITH LUNG ADENOCARCINOMA - IMPLICATIONS OF THE SHARED ANTIGENS EXPRESSED IN HLA-A24 LUNG-CANCER CELLS, Japanese journal of cancer research, 89(1), 1998, pp. 60-66
VACCINATION WITH ACTIVATED B-CELLS PULSED WITH TUMOR-LYSATES CAN INDUCE TUMOR-SPECIFIC CD4(-CELLS IN-VIVO() T)
Authors: ITO O HARADA M TAKENOYAMA M TAMADA K LI TL ABE K FUJIE H NOMOTO K
Citation: O. Ito et al., VACCINATION WITH ACTIVATED B-CELLS PULSED WITH TUMOR-LYSATES CAN INDUCE TUMOR-SPECIFIC CD4(-CELLS IN-VIVO() T), Immunobiology, 199(1), 1998, pp. 133-147
EXPRESSION OF THE MELANOMA ANTIGEN-ENCODING GENE IN HUMAN LUNG-CANCER
Authors: YOSHIMATSU T YOSHINO I OHGAMI A TAKENOYAMA M HANAGIRI T NOMOTO K YASUMOTO K
Citation: T. Yoshimatsu et al., EXPRESSION OF THE MELANOMA ANTIGEN-ENCODING GENE IN HUMAN LUNG-CANCER, Journal of surgical oncology, 67(2), 1998, pp. 126-129
SYSTEMIC ADMINISTRATION OF INTERLEUKIN-12 CAN RESTORE THE ANTITUMOR POTENTIAL OF B16 MELANOMA-DRAINING LYMPH-NODE CELLS IMPAIRED AT A LATE TUMOR-BEARING STATE
Authors: HARADA M TAMADA K ABE K LI TL ONOE Y TADA H TAKENOYAMA M YASUMOTO K KIMURA G NOMOTO K
Citation: M. Harada et al., SYSTEMIC ADMINISTRATION OF INTERLEUKIN-12 CAN RESTORE THE ANTITUMOR POTENTIAL OF B16 MELANOMA-DRAINING LYMPH-NODE CELLS IMPAIRED AT A LATE TUMOR-BEARING STATE, International journal of cancer, 75(3), 1998, pp. 400-405
THE INDUCTION OF CYTOTOXIC T-LYMPHOCYTES AGAINST HLA-A LOCUS-MATCHED LUNG ADENOCARCINOMA IN PATIENTS WITH NONSMALL CELL LUNG-CANCER
Authors: YOSHINO I TAKENOYAMA M FUJIE H HANAGIRI T YOSHIMATSU T IMABAYASHI S EIFUKU R OGAMI A YANO K OSAKI T NAKANISHI R ICHIYOSHI Y NOMOTO K YASUMOTO K
Citation: I. Yoshino et al., THE INDUCTION OF CYTOTOXIC T-LYMPHOCYTES AGAINST HLA-A LOCUS-MATCHED LUNG ADENOCARCINOMA IN PATIENTS WITH NONSMALL CELL LUNG-CANCER, Japanese journal of cancer research, 88(8), 1997, pp. 743-749
LOCAL INJECTION OF OK432 CAN AUGMENT THE TH1-TYPE T-CELL RESPONSE IN TUMOR-DRAINING LYMPH-NODE CELLS AND INCREASE THEIR IMMUNOTHERAPEUTIC POTENTIAL
Authors: OKAMOTO T HARADA M TAMADA K YOSHIDA H ITO O KONG YY TAKENOYAMA M HIRASHIMA C MATSUZAKI G NOMOTO K
Citation: T. Okamoto et al., LOCAL INJECTION OF OK432 CAN AUGMENT THE TH1-TYPE T-CELL RESPONSE IN TUMOR-DRAINING LYMPH-NODE CELLS AND INCREASE THEIR IMMUNOTHERAPEUTIC POTENTIAL, International journal of cancer, 70(5), 1997, pp. 598-605
ORAL-ADMINISTRATION OF PSK CAN IMPROVE THE IMPAIRED ANTITUMOR CD4(-CELL RESPONSE IN GUT-ASSOCIATED LYMPHOID-TISSUE (GALT) OF SPECIFIC-PATHOGEN-FREE MICE() T)
Authors: HARADA M MATSUNAGA K OGUCHI Y IIJIMA H TAMADA K ABE K TAKENOYAMA M ITO O KIMURA G NOMOTO K
Citation: M. Harada et al., ORAL-ADMINISTRATION OF PSK CAN IMPROVE THE IMPAIRED ANTITUMOR CD4(-CELL RESPONSE IN GUT-ASSOCIATED LYMPHOID-TISSUE (GALT) OF SPECIFIC-PATHOGEN-FREE MICE() T), International journal of cancer, 70(3), 1997, pp. 362-372
POSTOPERATIVE PROGNOSIS IN PATIENTS WITH NONSMALL CELL LUNG-CANCER WITH SYNCHRONOUS IPSILATERAL INTRAPULMONARY METASTASIS
Authors: YOSHINO I NAKANISHI R OSAKI T HASUDA S TAGA S TAKENOYAMA M YOSHIMATSU T YASUMOTO K
Citation: I. Yoshino et al., POSTOPERATIVE PROGNOSIS IN PATIENTS WITH NONSMALL CELL LUNG-CANCER WITH SYNCHRONOUS IPSILATERAL INTRAPULMONARY METASTASIS, The Annals of thoracic surgery, 64(3), 1997, pp. 809-813
PRODUCTION OF RECOMBINANT HUMAN MONOCLONAL-ANTIBODY USING RAS-AMPLIFIED BHK-21-CELLS IN A PROTEIN-FREE MEDIUM
Authors: INOUE Y LOPEZ LB KAWAMOTO S ARITA N TERUYA K SEKI K SHOJI M KAMEI M HASHIZUME S SHIOZAWA Y TACHIBANA H OHASHI H YASUMOTO K NAGASHIMA A NAKAHASHI H SUZUKI T IMAI T NOMOTO K TAKENOYAMA M KATAKURA Y SHIRAHATA S
Citation: Y. Inoue et al., PRODUCTION OF RECOMBINANT HUMAN MONOCLONAL-ANTIBODY USING RAS-AMPLIFIED BHK-21-CELLS IN A PROTEIN-FREE MEDIUM, Bioscience, biotechnology, and biochemistry, 60(5), 1996, pp. 811-817
THE ANTITUMOR EFFECT INDUCED BY LOCAL INJECTIONS WITH INTERLEUKIN-2 IS DIMINISHED BY COMBING WITH A LOCAL INJECTION WITH MITOMYCIN-C
Authors: LI TL HARADA M TAMADA K ABE K ITO O TAKENOYAMA M NOMOTO K
Citation: Tl. Li et al., THE ANTITUMOR EFFECT INDUCED BY LOCAL INJECTIONS WITH INTERLEUKIN-2 IS DIMINISHED BY COMBING WITH A LOCAL INJECTION WITH MITOMYCIN-C, Immunopharmacology and immunotoxicology, 18(4), 1996, pp. 497-509
EFFECTS OF INTERLEUKIN-12 ON IN-VITRO CULTURE WITH INTERLEUKIN-2 OF REGIONAL LYMPH-NODE LYMPHOCYTES FROM LUNG-CANCER PATIENTS
Authors: HANAGIRI T TAKENOYAMA M YOSHIMATSU T HIRASHIMA C YOSHINO I NAKANISHI K NAGASHIMA A NOMOTO K YASUMOTO K
Citation: T. Hanagiri et al., EFFECTS OF INTERLEUKIN-12 ON IN-VITRO CULTURE WITH INTERLEUKIN-2 OF REGIONAL LYMPH-NODE LYMPHOCYTES FROM LUNG-CANCER PATIENTS, Cancer immunology and immunotherapy, 43(2), 1996, pp. 87-93
EXPRESSION OF ACTIVATION-RELATED MOLECULES ON REGIONAL LYMPH-NODE LYMPHOCYTES IN HUMAN LUNG-CANCER
Authors: TAKENOYAMA M YASUMOTO K HARADA M MATSUZAKI G ISHIDA T SUGIMACHI K NOMOTO K
Citation: M. Takenoyama et al., EXPRESSION OF ACTIVATION-RELATED MOLECULES ON REGIONAL LYMPH-NODE LYMPHOCYTES IN HUMAN LUNG-CANCER, Immunobiology, 195(2), 1996, pp. 140-151
THE OPPOSITE EFFECT OF TUMOR-INFILTRATING NATURAL-KILLER-CELLS ON IN-VIVO PRIMING OF TUMOR-SPECIFIC CD8(-CELLS AND CD4(+) T-CELLS() T)
Authors: TERAO H HARADA M KUROSAWA S SHINOMIYA Y ITO O TAMADA K TAKENOYAMA M NOMOTO K
Citation: H. Terao et al., THE OPPOSITE EFFECT OF TUMOR-INFILTRATING NATURAL-KILLER-CELLS ON IN-VIVO PRIMING OF TUMOR-SPECIFIC CD8(-CELLS AND CD4(+) T-CELLS() T), Immunobiology, 195(2), 1996, pp. 172-186
INCREASE OF B-CELLS IN THE TUMOR-BEARING STATE HAS THE POTENTIAL TO INDUCE ANTITUMOR IMMUNITY
Authors: ITO O HARADA M TAKENOYAMA M SUMICHIKA H MATSUZAKI G NOMOTO K
Citation: O. Ito et al., INCREASE OF B-CELLS IN THE TUMOR-BEARING STATE HAS THE POTENTIAL TO INDUCE ANTITUMOR IMMUNITY, Immunobiology, 195(1), 1996, pp. 1-15
THE EMERGENCE OF NONCYTOLYTIC NK1.1(-CELLS IN THE LONG-TERM CULTURE OF MURINE TUMOR-INFILTRATING LYMPHOCYTES - A POSSIBLE ROLE OF TRANSFORMING GROWTH-FACTOR-BETA() T)
Authors: TAMADA K HARADA M ITO O TAKENOYAMA M MORI T MATSUZAKI G NOMOTO K
Citation: K. Tamada et al., THE EMERGENCE OF NONCYTOLYTIC NK1.1(-CELLS IN THE LONG-TERM CULTURE OF MURINE TUMOR-INFILTRATING LYMPHOCYTES - A POSSIBLE ROLE OF TRANSFORMING GROWTH-FACTOR-BETA() T), Immunology, 89(4), 1996, pp. 627-635
SPECIFIC IMMUNOTHERAPY WITH TUMOR-DRAINING LYMPH-NODE CELLS CULTURED WITH BOTH ANTI-CD3 AND ANTI-CD28 MONOCLONAL-ANTIBODIES
Authors: HARADA M OKAMOTO T OMOTO K TAMADA K TAKENOYAMA M HIRASHIMA C ITO O KIMURA G NOMOTO K
Citation: M. Harada et al., SPECIFIC IMMUNOTHERAPY WITH TUMOR-DRAINING LYMPH-NODE CELLS CULTURED WITH BOTH ANTI-CD3 AND ANTI-CD28 MONOCLONAL-ANTIBODIES, Immunology, 87(3), 1996, pp. 447-453
IL-3 DERIVED FROM CD4(-CELLS IS ESSENTIAL FOR THE IN-VITRO EXPANSION OF MAST-CELLS FROM THE NORMAL ADULT-MOUSE SPLEEN() T)
Authors: HARADA M SUMICHIKA H HAMANO S ITO O TAMADA K TAKENOYAMA M KIMURA G NOMOTO K
Citation: M. Harada et al., IL-3 DERIVED FROM CD4(-CELLS IS ESSENTIAL FOR THE IN-VITRO EXPANSION OF MAST-CELLS FROM THE NORMAL ADULT-MOUSE SPLEEN() T), Clinical and experimental immunology, 106(1), 1996, pp. 149-155
THE RELATIONSHIP BETWEEN THE IMMUNODETECTION OF TRANSFORMING GROWTH-FACTOR-BETA IN LUNG ADENOCARCINOMA AND LONGER SURVIVAL RATES
Authors: INOUE T ISHIDA T TAKENOYAMA M SUGIO K SUGIMACHI K
Citation: T. Inoue et al., THE RELATIONSHIP BETWEEN THE IMMUNODETECTION OF TRANSFORMING GROWTH-FACTOR-BETA IN LUNG ADENOCARCINOMA AND LONGER SURVIVAL RATES, Surgical oncology, 4(1), 1995, pp. 51-57
TH1 TYPE CD4(-CELLS MAY BE A POTENT EFFECTOR AGAINST POORLY IMMUNOGENIC SYNGENEIC TUMORS - ANTITUMOR-ACTIVITY OF TH1 TYPE CD4(+) T-CELLS() T)
Authors: TERAO H HARADA M KUROSAWA S SHINOMIYA Y OKAMOTO T ITO O SUMICHIKA H TAKENOYAMA M NOMOTO K
Citation: H. Terao et al., TH1 TYPE CD4(-CELLS MAY BE A POTENT EFFECTOR AGAINST POORLY IMMUNOGENIC SYNGENEIC TUMORS - ANTITUMOR-ACTIVITY OF TH1 TYPE CD4(+) T-CELLS() T), Biotherapy, 8(2), 1995, pp. 143-151
CONCOMITANT IMMUNITY AGAINST TUMOR-DEVELOPMENT IS ENHANCED BY THE ORAL-ADMINISTRATION OF A KAMPO MEDICINE, HOCHU-EKKI-TO (TJ-41-BU-ZHONG-YI-QI-TANG)
Authors: HARADA M SETA K ITO O TAMADA K LI T TERAO H TAKENOYAMA M KIMURA G NOMOTO K
Citation: M. Harada et al., CONCOMITANT IMMUNITY AGAINST TUMOR-DEVELOPMENT IS ENHANCED BY THE ORAL-ADMINISTRATION OF A KAMPO MEDICINE, HOCHU-EKKI-TO (TJ-41-BU-ZHONG-YI-QI-TANG), Immunopharmacology and immunotoxicology, 17(4), 1995, pp. 687-703
SPECIFIC ANTITUMOR-ACTIVITY OF TUMOR-INFILTRATING LYMPHOCYTES EXPANDED FIRST IN A CULTURE WITH BOTH ANTI-CD3 MONOCLONAL-ANTIBODY AND ACTIVATED B-CELLS AND THEN IN A CULTURE WITH INTERLEUKIN-2
Authors: TAMADA K HARADA M OKAMOTO T TAKENOYAMA M ITO O MATSUZAKI G NOMOTO K
Citation: K. Tamada et al., SPECIFIC ANTITUMOR-ACTIVITY OF TUMOR-INFILTRATING LYMPHOCYTES EXPANDED FIRST IN A CULTURE WITH BOTH ANTI-CD3 MONOCLONAL-ANTIBODY AND ACTIVATED B-CELLS AND THEN IN A CULTURE WITH INTERLEUKIN-2, Cancer immunology and immunotherapy, 41(6), 1995, pp. 339-347
LYMPH-NODE CANCER OF THE MEDIASTINAL OR HILAR REGION WITH AN UNKNOWN PRIMARY SITE
Authors: KOHDONO S ISHIDA T FUKUYAMA Y HAMATAKE M TAKENOYAMA M TATEISHI M SUGIMACHI K
Citation: S. Kohdono et al., LYMPH-NODE CANCER OF THE MEDIASTINAL OR HILAR REGION WITH AN UNKNOWN PRIMARY SITE, Journal of surgical oncology, 58(3), 1995, pp. 196-200
THE ANTITUMOR-ACTIVITY INDUCED BY THE IN-VIVO ADMINISTRATION OF ACTIVATED B-CELLS BOUND TO ANTI-CD3 MONOCLONAL-ANTIBODY
Authors: HARADA M OKAMOTO T KUROSAWA S SHINOMIYA Y ITO O TAKENOYAMA M TERAO H MATSUZAKI G KIMURA G NOMOTO K
Citation: M. Harada et al., THE ANTITUMOR-ACTIVITY INDUCED BY THE IN-VIVO ADMINISTRATION OF ACTIVATED B-CELLS BOUND TO ANTI-CD3 MONOCLONAL-ANTIBODY, Cellular immunology, 161(1), 1995, pp. 132-137
GENERATION OF TUMOR-SPECIFIC CYTOTOXIC T-LYMPHOCYTES IN-VIVO BY COMBINED TREATMENT WITH INACTIVATED TUMOR-CELLS AND RECOMBINANT INTERLEUKIN-2
Authors: HARADA M MATSUZAKI G SHINOMIYA Y KUROSAWA S ITO O OKAMOTO T TAKENOYAMA M SUMITIKA H NISHIMURA Y NOMOTO K
Citation: M. Harada et al., GENERATION OF TUMOR-SPECIFIC CYTOTOXIC T-LYMPHOCYTES IN-VIVO BY COMBINED TREATMENT WITH INACTIVATED TUMOR-CELLS AND RECOMBINANT INTERLEUKIN-2, Cancer immunology and immunotherapy, 38(5), 1994, pp. 332-338
Risultati: 1-25 |